Detablan, Joseph B.

HRN: 21-52-22  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/02/2022
CEFTRIAXONE 1G (VIAL)
07/02/2022
07/09/2022
IV DRIP
500mg
Q24h
PCAP-D
Waiting Final Action 
07/02/2022
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
07/02/2022
07/09/2022
IV DRIP
510mg
Q6H
PCAP-D
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: